We found that the down-regulation of SFMBT2 promotes the up-regulation of CXCL8, CCL2, CXCL10, and CCL20 expression in prostate cancer cells, resulting in elevated infiltration of preadipocytes and TAMs. The gene discussed is CCL2; the disease is prostate carcinoma.